Related references
Note: Only part of the references are listed.Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Lin Jia et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
Stefano Volpato et al.
ATHEROSCLEROSIS (2011)
TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
Victoria Watt et al.
ATHEROSCLEROSIS (2011)
TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2-, Sp1 Phosphorylation-, and NFκB-Dependent Manner
Jeffrey Chan et al.
CIRCULATION RESEARCH (2010)
Treatment With Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
Giorgio Zauli et al.
DIABETES (2010)
Association of serum TRAIL level with coronary artery disease
Katsuhito Mori et al.
THROMBOSIS RESEARCH (2010)
Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
Lorenzo Piemonti et al.
DIABETES CARE (2009)
Adenovirus-Mediated TRAIL Gene (Ad5hTRAIL) Delivery into Pancreatic Islets Prolongs Normoglycemia in Streptozotocin-Induced Diabetic Rats
Ercument Dirice et al.
HUMAN GENE THERAPY (2009)
Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
Paola Secchiero et al.
PLOS ONE (2009)
Death receptors and their ligands in atherosclerosis
Mary M. Kavurma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression, regulation and function of trail in atherosclerosis
Mary M. Kavurma et al.
BIOCHEMICAL PHARMACOLOGY (2008)
TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-κB and induction of insulin-like growth factor-1 receptor
Mary M. Kavurma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice
Fredrik Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro
Federica Corallini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?
Jenny E. Kanter et al.
CIRCULATION RESEARCH (2007)
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
Paola Secchiero et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice
Paola Secchiero et al.
CIRCULATION (2006)
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
Murray C. H. Clarke et al.
NATURE MEDICINE (2006)
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes
S Devaraj et al.
DIABETES (2006)
Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis
M Schoppet et al.
ATHEROSCLEROSIS (2006)
Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes
SS Im et al.
DIABETES (2005)
Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia
JP Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
HMG-CoA reductase, cholesterol 7α-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X
CK Roberts et al.
KIDNEY INTERNATIONAL (2004)
Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane
J Marks et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes
SE Lamhamedi-Cherradi et al.
DIABETES (2003)
Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice
SE Lamhamedi-Cherradi et al.
NATURE IMMUNOLOGY (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
Innate and acquired immunity in atherogenesis
CJ Binder et al.
NATURE MEDICINE (2002)
Expansive arterial remodeling is associated with increased neointimal macrophage foam cell content - The murine model of macrophage-rich carotid artery lesions
E Ivan et al.
CIRCULATION (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
SA Bustin
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2000)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: Studies in C57BL/6 apolipoprotein E knockout mice
E Sehayek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
